Women's Sexual Health in Livermore, CA

How Women's Sexual Health Treatment Works in Livermore, CA

Understanding Low Desire in Livermore

Low sexual desire is one of the most common sexual health concerns among women. When it is persistent, causes distress and is not explained by another condition, it may be called hypoactive sexual desire disorder, or HSDD. Causes can include hormonal changes, antidepressants, birth control, stress, fatigue, pain and relationship factors. Often several factors overlap. A good evaluation looks at all of them before choosing treatment.

Low Libido Treatment for Women

Low libido treatment begins with understanding what is behind the change. Your provider reviews medications that can lower desire, such as certain antidepressants, and checks for symptoms of menopause or thyroid issues. Simple changes, like adjusting a medication or addressing vaginal dryness, sometimes make a big difference. When medication is appropriate, options include flibanserin, PT-141 or oxytocin therapy. Treatment is tailored to your health and goals.

Flibanserin for Women in Livermore

Flibanserin, sold as Addyi, is FDA-approved for premenopausal women with acquired, generalized HSDD. It is a non-hormonal pill taken once daily at bedtime that works on serotonin and dopamine in the brain. Benefits build gradually, and providers usually assess results after about eight weeks. Because it can cause low blood pressure and fainting, alcohol must be avoided close to bedtime. It also interacts with many common medications.

PT-141 for Women

PT-141, or bremelanotide, is FDA-approved as Vyleesi for premenopausal women with acquired, generalized HSDD. It is an as-needed injection given under the skin at least 45 minutes before sexual activity. It acts on melanocortin receptors in the brain linked to desire. Nausea is the most common side effect, especially at first. It should not be used more than once in 24 hours or more than eight times a month.

Oxytocin Therapy in Livermore

Oxytocin is a hormone involved in bonding, touch and arousal. Some providers prescribe compounded oxytocin as a nasal spray or dissolving troche to support intimacy and arousal. This use is off-label, and compounded oxytocin is not FDA-approved. Research is limited and results vary from person to person. Your provider will explain the evidence honestly before considering it.

How a Provider Chooses Between Options

Your provider considers whether you are premenopausal or postmenopausal, since flibanserin and bremelanotide are approved for premenopausal women. They also weigh whether you prefer a daily pill or an as-needed option. Alcohol habits, blood pressure, heart health and current medications strongly shape the choice. Women who drink regularly may be better suited to PT-141 than flibanserin. Contributing factors like medication side effects are addressed first when possible.

Side Effects and Safety in Livermore

Flibanserin can cause dizziness, sleepiness, nausea and low blood pressure, especially with alcohol or certain drugs. PT-141 commonly causes nausea, flushing and headache and can briefly raise blood pressure. Oxytocin is generally well tolerated but can cause headache or nasal irritation. Women who are pregnant or trying to conceive need special review. Your provider monitors side effects and adjusts your plan.

How the Online Process Works

You begin with a short online questionnaire about your symptoms, menstrual and menopausal status, health history and medications. A licensed provider reviews your answers and may message you with follow-up questions. If treatment is appropriate, your prescription is sent to a licensed US pharmacy. Medication ships to your door in discreet packaging. Ongoing check-ins help you and your provider track progress.